Literature DB >> 5564924

Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis.

H E Paulus, M Siegel, E Mongan, R Okun, J J Calabro.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5564924     DOI: 10.1002/art.1780140412

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  19 in total

1.  Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis.

Authors:  S J Preston; M H Arnold; E M Beller; P M Brooks; W W Buchanan
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

2.  Proceedings: Kinetics of salicylate metabolism.

Authors:  T Gibson; G Zaphiropoulos; J Grove; B Widdop; D Berry
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

Review 3.  Correlation plasma levels, NSAID and therapeutic response.

Authors:  J P Famaey
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

Review 4.  Adverse reactions and interactions with aspirin. Considerations in the treatment of the elderly patient.

Authors:  J Karsh
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

5.  Influence of gastrectomy on aspirin absorption.

Authors:  S Mineshita
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

6.  Effect of indomethacin and related drugs on the calcium ion-dependent secretion of lysosomal and other enzymes by neutrophil polymorphonuclear leucocytes in vitro.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

Review 7.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

8.  Metabolism of salicylate during chronic aspirin therapy.

Authors:  R H Rumble; P M Brooks; M S Roberts
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

9.  Monitoring plasma concentrations of salicylate.

Authors:  M Mandelli; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

Review 10.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.